Skip to Content
Merck
  • Imaging approach to mechanistic study of nanoparticle interactions with the blood-brain barrier.

Imaging approach to mechanistic study of nanoparticle interactions with the blood-brain barrier.

ACS nano (2014-04-30)
Mattia Bramini, Dong Ye, Anna Hallerbach, Michelle Nic Raghnaill, Anna Salvati, Christoffer Aberg, Kenneth A Dawson
ABSTRACT

Understanding nanoparticle interactions with the central nervous system, in particular the blood-brain barrier, is key to advances in therapeutics, as well as assessing the safety of nanoparticles. Challenges in achieving insights have been significant, even for relatively simple models. Here we use a combination of live cell imaging and computational analysis to directly study nanoparticle translocation across a human in vitro blood-brain barrier model. This approach allows us to identify and avoid problems in more conventional inferential in vitro measurements by identifying the catalogue of events of barrier internalization and translocation as they occur. Potentially this approach opens up the window of applicability of in vitro models, thereby enabling in depth mechanistic studies in the future. Model nanoparticles are used to illustrate the method. For those, we find that translocation, though rare, appears to take place. On the other hand, barrier uptake is efficient, and since barrier export is small, there is significant accumulation within the barrier.

MATERIALS
Product Number
Brand
Product Description

Supelco
Hydrocortisone, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Hydrocortisone, γ-irradiated, powder, BioXtra, suitable for cell culture
Sigma-Aldrich
Hydrocortisone, ≥98% (HPLC)
Sigma-Aldrich
Hydrocortisone, BioReagent, suitable for cell culture
Hydrocortisone, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Hydrocortisone, meets USP testing specifications
Hydrocortisone, British Pharmacopoeia (BP) Assay Standard
Sigma-Aldrich
DAPI, for nucleic acid staining